Wegovy Cost in 2026: What You’ll Really Pay & How to Save
The list price of Wegovy is $1,329 per month, but most patients pay far less once coupons, insurance, or pharmacy shopping are factored in. Here’s the complete 2026 playbook.
Wegovy (semaglutide) is one of the most effective FDA-approved weight-loss medications, but its list price—about $1,329 for a month’s supply—can be shocking. In 2026, real-world out-of-pocket costs now span $25 to $399 when insurance or manufacturer discounts apply and $1,200 to $1,500 when they don’t. Understanding which price tier fits your situation—and how to move down the ladder—can save you thousands of dollars a year.
- The current U.S. list price of Wegovy is roughly $1,329 for four single-dose pens, regardless of dose strength. [healthline.com]
- About 23 % of commercial health plans cover Wegovy for obesity in 2026, most with prior authorization and step-therapy rules. [glp1.tools]
- Uninsured patients can drop the price to $199–$349 a month by using NovoCare Direct, Rx.com coupons, or a long-term subscription plan. [glp1picks.com]
- Alternatives like Compunded Semaglutide / Tirzepatide, Ozempic, Mounjaro, and Trulicity have similar list prices but very different discount programs.
- Most people experience the highest out-of-pocket cost during the first 90 days while appeals and savings cards process—planning ahead avoids sticker shock.
What Wegovy Is & Why It Works
Wegovy is an injectable form of semaglutide—a GLP-1 receptor agonist—that signals fullness, slows stomach emptying, and reduces hunger. The FDA first approved the 2.4 mg weekly dose for chronic weight management in adults with obesity in June 2021, then cleared even higher “HD” doses in March 2026 for patients needing additional weight loss. [fda.gov]
Definition: Wegovy is an FDA-approved, once-weekly semaglutide injection indicated for adults with a body-mass index (BMI) ≥30 kg/m2, or ≥27 kg/m2 with at least one weight-related condition.
In clinical trials, adults using Wegovy lost an average of 14 % of their body weight at 68 weeks, outperforming every other branded anti-obesity medication on the U.S. market. [pubmed.ncbi.nlm.nih.gov]
Why Wegovy Costs So Much
The sticker price combines specialty manufacturing, high demand, and limited competition. Unlike pills, Wegovy pens contain a biologic peptide that requires cold-chain transport and single-use injector assembly—two cost multipliers.
Limited competition: Although Mounjaro and its weight-loss twin Zepbound have joined the market, no biosimilar semaglutide exists and patents extend to 2033.
Supply constraints: Wegovy appeared on the FDA drug shortage list in 2023 and again in early 2026. [fda.gov] Manufacturers allocate product first to insured channels, keeping cash prices high.
Research recoup: Novo Nordisk spent an estimated $2 billion on the STEP development program and continues to run cardiovascular-outcome trials funded by drug revenue.
Cash Price: What You’ll Pay Without Insurance
If you walk into a retail pharmacy today with no coverage, Wegovy rings up between $1,200 and $1,500. Prices vary by dose strength only a few dollars because each carton contains pens calibrated for titration.
| Pharmacy chain (U.S.) | Average cash price (June 2026) |
|---|---|
| CVS / Target | $1,325 |
| Walgreens | $1,312 |
| Walmart | $1,302 |
| Kroger | $1,287 |
| Independent (average of 50 stores) | $1,341 |
Pro tip: Use Rx.com to compare prices—most cash-pay patients secure Wegovy for $1,048 or less with a free discount card.
How Insurance Covers Wegovy in 2026
Roughly one in four commercial plans now cover Wegovy, but requirements are strict. Medicare still excludes weight-loss drugs, though a bipartisan bill remains in committee.
| Plan type | % covering Wegovy | Typical copay | Key hurdles |
|---|---|---|---|
| Large-group employer | 31 % | $25–$150 | Prior authorization, yearly re-certification |
| Small-group employer | 19 % | $75–$300 | 6-month lifestyle program first |
| ACA Marketplace | 14 % | $85–$400 | Step therapy (try generic phentermine) |
| Medicaid (state avg.) | 8 % | $3–$15 | BMI ≥35 kg/m2, comorbidities proof |
| Medicare Part D | 0 % | N/A | Statutory exclusion |
Appeals matter: Forty-four percent of denied Wegovy prior authorization requests are approved on first appeal when doctors supply STEP trial data and cardiometabolic risk scores.
Connect With a Licensed Weight-Loss Provider
Start or transfer your Wegovy prescription online in minutes—and see the lowest local prices first.
Six Proven Ways to Cut Your Wegovy Bill
You have more leverage than you think. Stack the following strategies until you reach an affordable monthly number.
1. Manufacturer savings card: NovoCare offers up to $200 off each fill for eligible commercial-insured patients, dropping copays to as low as $25.
2. NovoCare Direct subscription: Uninsured? Lock in $199 per month for the first two titration packs and $349 thereafter by committing to a 12-month plan. [axios.com]
3. Price shop with Rx.com: Enter your zip code to reveal pharmacy-level prices; savings average 21 % versus national cash price.
4. Appeal insurance denials: Use clinical letters citing average 14 % weight reduction and cardiovascular-risk data to meet “medical necessity.”
5. Compare alternative GLP-1s: Some payers prefer Mounjaro or Ozempic; switching can cut copays in half.
6. Temporary bridge programs: State Medicaid Buy-In or employer obesity-wellness funds can reimburse the first 6–12 months while appeals proceed.
For deeper tactics, see our complete GLP-1 cost guide.
Can you afford Wegovy right now?
Check the column that fits your situation:
✅ Good to Start
- Monthly budget after discounts is under $350
- BMI ≥27 kg/m2 with a weight-related condition
- No contraindicated GI disorders
- Able to commit to weekly injections and follow-ups
🏥 Re-evaluate First
- Out-of-pocket remains above $400 after stacking discounts
- Denied insurance appeal with no further recourse
- History of medullary thyroid carcinoma or MEN 2
- Uncontrolled pancreatitis or gallbladder disease
Wegovy vs. Other GLP-1 Prices
The headline prices are almost identical, but net costs diverge once coupons and coverage rules kick in.
| Drug (weekly) | Indication | List price (June 2026) | Lowest realistic cash price |
|---|---|---|---|
| Wegovy 2.4 mg | Obesity | $1,329 | $199–$399 |
| Ozempic 2.0 mg | Type 2 diabetes* | $1,024 | $25–$350 |
| Mounjaro 15 mg | Type 2 diabetes* | $1,215 | $25–$550 |
| Zepbound 15 mg | Obesity | $1,215 | $550–$715 |
| Trulicity 4.5 mg | Type 2 diabetes* | $968 | $25–$430 |
*Many prescribers use these GLP-1s off-label for weight loss when Wegovy is inaccessible. Learn more in our GLP-1 decision guide.
Is Wegovy the Right Financial Fit?
Run the math before you inject the first pen. Multiply your likely monthly net cost by 12; if the number strains your budget, talk with your provider about dose spacing, a temporary stop-start cycle, or switching to lower-cost tirzepatide.
Remember: weight-loss maintenance often requires long-term therapy. Stopping Wegovy without a lifestyle plan leads to about two-thirds weight regain within a year, according to STEP-4 data. Build the cost into your multi-year plan, not just the first fill.
🚨 When to Contact Your Healthcare Provider
Contact your doctor immediately if you experience any of the following:
- Severe abdominal pain — could signal pancreatitis, a known but rare GLP-1 complication
- Persistent nausea or vomiting — risk of dehydration and electrolyte imbalance
- Yellowing of skin or eyes — possible gallbladder inflammation
- Lump or swelling in the neck — potential thyroid tumor; stop injections until evaluated
- Difficulty swallowing or breathing — could indicate allergic reaction to the injection
- Rapid heartbeat or dizziness — may reflect dehydration or hypoglycemia when combined with diabetes meds
- Changes in vision — sudden eye pain can be a diabetic retinopathy flare when weight drops quickly
- Severe injection-site reaction — redness, hardness, or itching lasting >5 days
Scientific References
- Ghoshal M. Wegovy Cost 2026: Average Price and Ways to Save. Healthline, 2026.
- Kerkvliet J et al. Cost-effectiveness analysis of semaglutide 2.4 mg for overweight and obesity in the United States. Clin Ther, 2022.
- FDA. Approval of Wegovy HD (higher-dose semaglutide). Press Release, March 2026.
- GLP1.tools. Semaglutide Cost: What You’ll Pay in 2025-26. Accessed June 2026.
- Herman B. Novo tests new Wegovy pricing as competition intensifies. Axios, 2026.
- FDA. Dosing errors associated with compounded injectable semaglutide products. Safety Communication, 2025.
Frequently Asked Questions
Does health insurance ever cover Wegovy for weight loss?
Yes. About one-quarter of commercial plans include Wegovy when medical criteria are met, but prior authorization is almost universal. Medicare still excludes weight-loss drugs unless Congress changes the law.
Can I use an FSA or HSA to pay for Wegovy?
Absolutely. Wegovy is an FDA-approved prescription medication, so payments qualify as eligible medical expenses. Save every receipt for tax time.
Is compounded semaglutide a safe cheaper alternative?
The FDA warns of dosing errors and unapproved salt forms in many compounded products. If you consider this route, vet the 503A pharmacy carefully and discuss risks with your prescriber.
Will weight regain happen if I stop Wegovy after a few months?
Likely, yes. STEP-4 showed participants regained roughly two-thirds of lost weight within one year of stopping therapy, highlighting the need for long-term maintenance.
How long do manufacturer coupons last?
Most NovoCare Wegovy savings cards run through December 31 of the calendar year issued, with a maximum annual benefit of $3,600. Re-enroll each January.
Does dose strength change the price?
No. Wegovy cartons are priced the same for 0.25 mg through 2.4 mg doses because each contains four pens calibrated for weekly escalation.
Can I split a pen to make Wegovy last longer?
No. Pens are single-use devices without accurate re-capping mechanisms. Splitting doses risks contamination, under-dosing, and insurance rejection.
Is there a generic for Wegovy?
Not yet. Patent protection extends until at least 2033, so true generics are unlikely before then. Any “generic semaglutide” currently marketed for weight loss is compounded and not FDA-approved.
Ready to Find Your Lowest Wegovy Price?
Compare live pharmacy prices or connect with a telehealth provider who can activate manufacturer savings—all in one visit.